Ondansetron HCL 4 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB26FW4K0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,257
Award facts
- Contract value 100% obligated
- $13,257.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Ondansetron HCL 4 mg tablets (500-count) with a ceiling value of $13,257.46. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. The order is scheduled for ultimate completion by October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative recovery.
This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition, combined with its extensive contract portfolio across multiple therapeutic domains, positions the company as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FW4K0?
SPE2DB26FW4K0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FW4K0 worth?
The government has obligated $13,257 on SPE2DB26FW4K0.
Is contract SPE2DB26FW4K0 an order under another contract?
Yes. SPE2DB26FW4K0 is a delivery order under SPE2DB20D3304, an indefinite delivery contract.
Was contract SPE2DB26FW4K0 competed?
The extent of competition for SPE2DB26FW4K0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award